Firm News
Wiggin and Dana Represents Meda AB in 3M’s $2.1 billion Divestment of 3M’s Pharmaceutical Business
STAMFORD, CT. – Meda AB, a leading European specialty pharmaceutical company, announced it will acquire 3M's European pharmaceutical business for $857 million. Pending regulatory approval, the transaction will close in late 2006 or early 2007.